LB-102 for acute schizophrenia in adults: efficacy and safety from a large phase 2 clinical trial

Neuroscience Applied 2026 Open access

Read full text

Authors: A. Eramo, L. Callahan, N. Bassani, B.P. Lee, Z. Prensky, A.R. Vaino, J.M. Kane

DOI: 10.1016/j.nsa.2025.106836

Cited by: 1

Fields of Study & Subjects

Schizophrenia research and treatment Tryptophan and brain disorders Pharmacological Receptor Mechanisms and Effects